Anticholinergic burden and risk of cognitive impairment in elderly nursing home residents with depression.

MLA

Chatterjee, Satabdi, et al. “Anticholinergic Burden and Risk of Cognitive Impairment in Elderly Nursing Home Residents with Depression.” Research in Social & Administrative Pharmacy : RSAP, vol. 16, no. 3, Mar. 2020, pp. 329–35. EBSCOhost, https://doi.org/10.1016/j.sapharm.2019.05.020.

APA

Chatterjee, S., Bali, V., Carnahan, R. M., Chen, H., Johnson, M. L., & Aparasu, R. R. (2020). Anticholinergic burden and risk of cognitive impairment in elderly nursing home residents with depression. Research in Social & Administrative Pharmacy : RSAP, 16(3), 329–335. https://doi.org/10.1016/j.sapharm.2019.05.020

Chicago

Chatterjee, Satabdi, Vishal Bali, Ryan M Carnahan, Hua Chen, Michael L Johnson, and Rajender R Aparasu. 2020. “Anticholinergic Burden and Risk of Cognitive Impairment in Elderly Nursing Home Residents with Depression.” Research in Social & Administrative Pharmacy : RSAP 16 (3): 329–35. doi:10.1016/j.sapharm.2019.05.020.